Itching sensation in psoriatic @entity1 and its relation to body mass index and XXXX and @entity22597 concentrations.

@entity1 @entity1569 @entity22597 @entity111 @entity4155 @entity272
INTRODUCTION: According to available data, @entity111 is a common symptom of @entity1569 , however its characteristics and pathogenesis are not clearly understood. AIM: The main aim of this study was to assess itching sensation among @entity1 suffering from @entity1569 , including its incidence and severity. All factors triggering and worsening pruritic symptoms were also carefully analyzed. The authors assessed the relationship of itch with body mass index (BMI) and severity of disease. Moreover, serum levels of @entity4155 ( @entity4155 ) and @entity22597 were analyzed in relation to Psoriasis Activity and Severity Index, BMI and severity of @entity111 . MATERIAL AND METHODS: The study group consisted of 60 @entity1 with @entity1569 . Analysis of impact of @entity111 on the quality of life and worsening factors was based on the questionnaire. The severity of @entity111 was assessed with the use of two independent scales. Serum @entity4155 and @entity22597 levels were measured in 30 @entity1 suffering from @entity1569 and in 10 healthy controls using immunoassay tests. RESULTS: 88.3% of analyzed @entity1 complained of itch and the most common factor which exacerbated @entity111 was stress (39.6%). @entity111 in @entity1569 was independent of gender, illness duration and extent of @entity272 . The average intensity of @entity111 was assessed as moderate and did not correlate significantly with BMI level, @entity4155 and @entity22597 . CONCLUSIONS: Since the pathogenesis of @entity111 in @entity1569 is not fully understood, further investigation in this area needs to be conducted. @entity111 may be considered as a characteristic feature of @entity1569 and, besides the @entity272 , should be a target in dermatological treatment to improve @entity1 's quality of life.
